Smetak M - Search Results

1

First-line therapy of peripheral T-cell lymphoma: extension and long-term follow-up of a study investigating the role of autologous stem cell transplantation.

Wilhelm M, Smetak M, Reimer P, Geissinger E, Ruediger T, Metzner B, Schmitz N, Engert A, Schaefer-Eckart K, Birkmann J. Wilhelm M, et al. Among authors: smetak m. Blood Cancer J. 2016 Jul 29;6(7):e452. doi: 10.1038/bcj.2016.63. Blood Cancer J. 2016. PMID: 27471868 Free PMC article.

2

Successful adoptive transfer and in vivo expansion of haploidentical γδ T cells.

Wilhelm M, Smetak M, Schaefer-Eckart K, Kimmel B, Birkmann J, Einsele H, Kunzmann V. Wilhelm M, et al. Among authors: smetak m. J Transl Med. 2014 Feb 15;12:45. doi: 10.1186/1479-5876-12-45. J Transl Med. 2014. PMID: 24528541 Free PMC article. Clinical Trial.

3

Clinical-scale single-step CD4(+) and CD8(+) cell depletion for donor innate lymphocyte infusion (DILI).

Smetak M, Kimmel B, Birkmann J, Schaefer-Eckart K, Einsele H, Wilhelm M, Kunzmann V. Smetak M, et al. Bone Marrow Transplant. 2008 Apr;41(7):643-50. doi: 10.1038/sj.bmt.1705942. Epub 2007 Nov 26. Bone Marrow Transplant. 2008. PMID: 18037935

4

Immune cells regulate VEGF signalling via release of VEGF and antagonistic soluble VEGF receptor-1.

Hoeres T, Wilhelm M, Smetak M, Holzmann E, Schulze-Tanzil G, Birkmann J. Hoeres T, et al. Among authors: smetak m. Clin Exp Immunol. 2018 Apr;192(1):54-67. doi: 10.1111/cei.13090. Epub 2018 Jan 4. Clin Exp Immunol. 2018. PMID: 29235095 Free PMC article.

5

PD-1 signaling modulates interferon-γ production by Gamma Delta (γδ) T-Cells in response to leukemia.

Hoeres T, Holzmann E, Smetak M, Birkmann J, Wilhelm M. Hoeres T, et al. Among authors: smetak m. Oncoimmunology. 2018 Dec 14;8(3):1550618. doi: 10.1080/2162402X.2018.1550618. eCollection 2019. Oncoimmunology. 2018. PMID: 30723581 Free PMC article.

6

Improving Immunotherapy Against B-Cell Malignancies Using γδ T-Cell-specific Stimulation and Therapeutic Monoclonal Antibodies.

Hoeres T, Pretscher D, Holzmann E, Smetak M, Birkmann J, Triebel J, Bertsch T, Wilhelm M. Hoeres T, et al. Among authors: smetak m. J Immunother. 2019 Nov/Dec;42(9):331-344. doi: 10.1097/CJI.0000000000000289. J Immunother. 2019. PMID: 31318724

7

LW/SO cell line: a tool for studying the phenotypical characterization and commitment of hematopoietic stem cells.

Oez S, Trautmann U, Smetak M, Birkmann J, al salemeh S, Gebhart E, Gallmeier WM. Oez S, et al. Among authors: smetak m. Ann Hematol. 1996 May;72(5):307-16. doi: 10.1007/s002770050177. Ann Hematol. 1996. PMID: 8645743

8

Tumor-promoting versus tumor-antagonizing roles of γδ T cells in cancer immunotherapy: results from a prospective phase I/II trial.

Kunzmann V, Smetak M, Kimmel B, Weigang-Koehler K, Goebeler M, Birkmann J, Becker J, Schmidt-Wolf IG, Einsele H, Wilhelm M. Kunzmann V, et al. Among authors: smetak m. J Immunother. 2012 Feb-Mar;35(2):205-13. doi: 10.1097/CJI.0b013e318245bb1e. J Immunother. 2012. PMID: 22306909 Clinical Trial.

9

Improving the Efficiency of Vγ9Vδ2 T-Cell Immunotherapy in Cancer.

Hoeres T, Smetak M, Pretscher D, Wilhelm M. Hoeres T, et al. Among authors: smetak m. Front Immunol. 2018 Apr 19;9:800. doi: 10.3389/fimmu.2018.00800. eCollection 2018. Front Immunol. 2018. PMID: 29725332 Free PMC article. Review.

10

Reduction of HLA-DR+ lymphocytes after treatment with enzastaurin in patients with metastatic thyroid cancer.

Smetak M, Weigang-Koehler K, Hanauske A, Ohnmacht U, Lahn M, Wilhelm M, Birkmann J. Smetak M, et al. Chemotherapy. 2008;54(4):268-73. doi: 10.1159/000149717. Epub 2008 Jul 31. Chemotherapy. 2008. PMID: 18667816

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

43 results

Search Page

Filters